Understanding Cyclin B's Role in The Cell Cycle (P10931)

Target Name: Cyclin B

NCBI ID: P10931

Cyclin B

Other Name(s): None

Understanding Cyclin B's Role in The Cell Cycle

Cyclin B, also known as cyclin D1, is a protein that is found in all living cells. It plays a critical role in the cell cycle, which is the process by which a cell grows, replicates its DNA, and divides. Cyclin B is a key component of the G1 phase of the cell cycle, which is when the cell prepares for cell division.

Cyclin B is a subunit of the cyclin D1 complex, which consists of three subunits: cyclin D1, cyclin D2, and cyclin D3. The cyclin D1 subunit consists of a 20 amino acid chain that contains a unique farnesylated cysteine 鈥嬧?媟esidue. This cysteine 鈥嬧?媟esidue is important for the stability and function of the cyclin D1 subunit.

Cyclin B has been shown to play a critical role in the regulation of cell growth and division. It is involved in the determination of the length of the cell cycle, as well as the timing of cell division. In addition, Cyclin B is involved in the regulation of cell surface tension, which is the force that holding the cell together.

Cyclin B is also a drug target and has been identified as a potential therapeutic target for various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the main advantages of targeting Cyclin B is that it is highly druggable. Cyclin B has a small number of potential drug binding sites, making it easier for drugs to interact with and inhibit its function. Additionally, Cyclin B is a protein that is expressed in high levels in many different types of cells, which makes it an attractive target for drugs that are effective in a broad range of cell types.

Another advantage of Cyclin B is its role in cell division. As the cell prepares for cell division, Cyclin B plays a critical role in ensuring that the chromosomes are properly organized and that the cell divides correctly. In addition, Cyclin B is involved in the regulation of cell surface tension, which is important for the stability of the cell.

Cyclin B has also been shown to be involved in the regulation of cell growth and the length of the cell cycle. It is involved in the determination of the length of the G1 phase of the cell cycle and in the regulation of cell proliferation.

In addition to its role in the cell cycle, Cyclin B is also involved in the regulation of cell adhesion. It is a component of the tight junction, which is a type of cell adhesion that helps to maintain the integrity of the cell membrane.

Cyclin B is also a potential biomarker for some diseases. For example, it is has been shown to be elevated in the blood of patients with certain types of cancer, which could be used as a biomarker for the diagnosis of these diseases. Additionally, Cyclin B is also a potential biomarker for some diseases. B has also been shown to be elevated in the brain of patients with neurodegenerative diseases, which could be used as a biomarker for the diagnosis of these diseases.

In conclusion, Cyclin B is a protein that plays a critical role in the cell cycle and the regulation of cell growth and division. It is a potential drug target and a potential biomarker for various diseases. Further research is needed to fully understand the function of Cyclin B and its potential as a therapeutic target.

Protein Name: Cyclin B (nonspecified Subtype)

The "Cyclin B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Cyclin B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets